Workplace Mental Health Prevention: Psychosocial Safety Climate, Organizational Interventions, and Return-to-Work Programs — A Clinical and Neurobiological Review

Mental health conditions are the leading cause of disability worldwide, and the workplace is both a major risk factor and a critical intervention point. The World Health Organization estimates that depression and anxiety disorders cost the global economy approximately $1 trillion per year in lost productivity. In high-income countries, between 30% and 50% of all disability benefit claims are attributable to mental health conditions, with common mental disorders — major depressive disorder (MDD), generalized anxiety disorder (GAD), adjustment disorders, and burnout-related syndromes — dominating the landscape.

Epidemiological data consistently demonstrates that approximately 15% of working-age adults experience a diagnosable mental disorder at any given time (WHO, 2022). The EU-OSHA estimates that 50–60% of all lost working days in Europe are related to work-related stress and psychosocial hazards. In Australia, national compensation data reveals that psychological injury claims, though comprising only 6–7% of all workers' compensation claims, account for disproportionately high costs — averaging $55,000 AUD per claim compared to $12,000 for physical injury claims — and are associated with significantly longer return-to-work trajectories, with median time loss of 32 weeks versus 5.5 weeks for musculoskeletal injuries.

These figures underscore that workplace mental health is not merely a wellness concern but a major clinical, economic, and public health priority. This article provides a deep clinical review of the psychosocial safety climate framework, organizational intervention modalities, return-to-work (RTW) programs, their neurobiological underpinnings, and the evidence base for their effectiveness.

Understanding why workplace psychosocial hazards produce clinical mental health conditions requires specificity about neurobiological mechanisms. Chronic occupational stress engages overlapping neural, endocrine, and immunological pathways that, when persistently activated, transition from adaptive stress responses to pathological states.

The Hypothalamic-Pituitary-Adrenal (HPA) Axis

The HPA axis is the central neuroendocrine stress response system. Under acute stress, corticotropin-releasing hormone (CRH) from the paraventricular nucleus of the hypothalamus stimulates adrenocorticotropic hormone (ACTH) release from the anterior pituitary, which in turn drives cortisol secretion from the adrenal cortex. Cortisol provides negative feedback to the hippocampus, hypothalamus, and prefrontal cortex (PFC) to terminate the response. Under chronic workplace stress — particularly in conditions of high demand, low control, and low support (the demand-control-support model) — this negative feedback loop becomes dysregulated. Studies by Chandola et al. (2006), using data from the Whitehall II cohort, demonstrated that workers exposed to chronic work stress showed flattened diurnal cortisol slopes, elevated evening cortisol, and impaired cortisol awakening responses — a pattern associated with metabolic syndrome, depression, and cardiovascular disease.

Prefrontal-Amygdala Circuit Dysregulation

The medial prefrontal cortex (mPFC) exerts top-down inhibitory control over the amygdala, enabling cognitive reappraisal, emotion regulation, and contextual fear discrimination. Chronic stress exposure produces dendritic atrophy in mPFC pyramidal neurons (particularly in the infralimbic and prelimbic regions) while simultaneously causing dendritic hypertrophy in the basolateral amygdala. This neuroplastic remodeling, extensively documented in animal models by Radley et al. (2004, 2006), shifts the functional balance toward amygdala-driven threat reactivity, reduced cognitive flexibility, and impaired executive function — the neurocognitive hallmarks of anxiety and depressive disorders. Functional neuroimaging studies in humans with burnout confirm reduced mPFC gray matter volume, weakened prefrontal-amygdala functional connectivity, and exaggerated amygdala reactivity to social-evaluative stimuli.

Neurotransmitter Systems

Chronic stress depletes serotonergic neurotransmission in the dorsal raphe nucleus, reduces dopaminergic signaling in the mesolimbic pathway (particularly in the nucleus accumbens and ventral tegmental area), and increases noradrenergic tone from the locus coeruleus. These changes map onto the clinical phenomenology of workplace-related mental health conditions: serotonin depletion contributes to mood dysregulation, irritability, and sleep disruption; dopaminergic suppression underlies anhedonia, motivational deficits, and cognitive fatigue (core features of burnout); and noradrenergic hyperactivation produces hypervigilance, concentration difficulties, and autonomic hyperarousal.

Neuroinflammation and the Immune-Brain Axis

Chronic psychosocial stress activates the innate immune system through sympathetic nervous system–mediated upregulation of NF-κB transcription pathways in monocytes and macrophages, increasing production of pro-inflammatory cytokines including IL-6, IL-1β, and TNF-α. These peripheral inflammatory mediators cross the blood-brain barrier and activate microglia, producing neuroinflammation that impairs serotonin synthesis (via shunting of tryptophan metabolism toward the kynurenine pathway), reduces BDNF (brain-derived neurotrophic factor) expression, and produces the "sickness behavior" phenotype that closely resembles depression. Meta-analytic evidence (Dowlati et al., 2010) confirms elevated IL-6 and TNF-α in MDD, with effect sizes of d = 0.62 and d = 0.40, respectively. Workers in high-stress occupations show elevated inflammatory biomarkers even in the absence of diagnosable depression, suggesting a pre-clinical vulnerability window where organizational intervention could be maximally effective.

Epigenetic and Genetic Vulnerability

Gene-environment interactions moderate individual susceptibility. The serotonin transporter gene-linked polymorphic region (5-HTTLPR) short allele, carried by approximately 40–45% of European populations, is associated with increased amygdala reactivity to psychosocial stress and higher rates of depression following adverse workplace events — although the strength of this association remains debated after Risch et al.'s (2009) meta-analysis found inconsistent effects. More robust evidence supports epigenetic mechanisms: chronic stress produces hypermethylation of the glucocorticoid receptor gene (NR3C1) and BDNF gene promoter regions, reducing receptor expression and neuroplasticity capacity. These epigenetic changes are partially reversible, providing a biological rationale for early intervention.

Psychosocial Safety Climate (PSC) is a construct developed by Maureen Dollard and colleagues at the University of South Australia, defined as "the shared perceptions of organizational policies, practices, and procedures for the protection of worker psychological health and safety" (Dollard & Bakker, 2010). PSC is distinguished from general organizational climate measures by its specific focus on management priority for psychological health, organizational communication about psychological safety, organizational participation and involvement, and management commitment enacted through resource allocation.

The PSC-12 and Measurement

PSC is measured using the PSC-12 scale, a validated 12-item instrument assessing four domains: (1) management commitment, (2) management priority, (3) organizational communication, and (4) organizational participation. Scores range from 12 to 60, with a clinically and epidemiologically significant benchmark established at a mean score of 41 — organizations scoring below this threshold demonstrate significantly elevated rates of worker psychological distress, burnout, depression, and sickness absence.

PSC as an Upstream "Cause of the Causes"

PSC functions as a leading indicator — an organizational-level determinant that precedes and predicts downstream psychosocial hazard exposure. In the landmark Australian Workplace Barometer (AWB) study, a nationally representative longitudinal survey of over 6,000 workers across two time points, Dollard and colleagues demonstrated that PSC at Time 1 predicted job demands and job resources at Time 2, which in turn predicted depression and emotional exhaustion at Time 2. Critically, PSC explained variance in worker mental health beyond that accounted for by individual job demands and resources, supporting its conceptualization as a macro-level organizational climate construct — what Dollard terms the "cause of the causes."

Epidemiological Data and Dose-Response Relationships

Data from the AWB revealed that workers in low-PSC organizations (bottom quartile) had a three- to fourfold increased risk of developing clinically significant depression over the study period compared to workers in high-PSC organizations. The population attributable fraction (PAF) for depression due to low PSC was estimated at approximately 18% — meaning that nearly one in five cases of new-onset depression in the working population could theoretically be prevented by improving PSC to adequate levels. This PAF is comparable to or exceeds those for more commonly targeted risk factors such as physical inactivity and smoking for cardiovascular disease.

Cross-national validation studies have replicated PSC's predictive validity in Malaysia, Japan, the Netherlands, Canada, and several European countries, confirming its robustness across cultural and economic contexts.

Clinicians evaluating work-related mental health presentations face several diagnostic challenges. The primary conditions encountered include major depressive disorder, generalized anxiety disorder, adjustment disorders, post-traumatic stress disorder (in high-risk occupations), and the contested but increasingly recognized syndrome of occupational burnout.

Adjustment Disorders vs. Major Depression

Adjustment disorder (AD) is defined in the DSM-5-TR as the development of emotional or behavioral symptoms in response to an identifiable stressor, occurring within three months of stressor onset, with marked distress disproportionate to the stressor or significant functional impairment. The ICD-11 provides a more specific definition, requiring a preoccupation with the stressor and failure to adapt. In the workplace setting, adjustment disorders are extremely common — estimated to account for 30–40% of work-related mental health sickness absence claims — yet are frequently under-diagnosed or conflated with MDD. The critical distinction is that AD, by definition, does not meet full criteria for another mental disorder. However, approximately 20–25% of adjustment disorders progress to MDD within 12 months if the stressor persists, making early intervention and stressor modification essential.

Burnout

Burnout is classified in the ICD-11 under QD85 ("Burnout") as an occupational phenomenon, not a medical diagnosis. It is defined by three dimensions: (1) emotional exhaustion, (2) depersonalization/cynicism, and (3) reduced professional efficacy. The DSM-5-TR does not include burnout as a diagnosis. Clinically, burnout presents with substantial overlap with MDD — meta-analytic data from Bianchi et al. (2015) found correlations between burnout and depression measures of r = 0.52–0.67, raising nosological questions about whether burnout represents a distinct construct or a work-contextualized subtype of depression. The practical implication is that clinicians must conduct full diagnostic assessment rather than accepting burnout as a sufficient clinical formulation, as approximately 50% of individuals with severe burnout meet criteria for MDD and require appropriate treatment.

Differential Diagnosis Pitfalls

Common pitfalls include: (1) attributing all symptoms to workplace stress when a comorbid primary disorder is present — for instance, an underlying bipolar II disorder, ADHD, or generalized anxiety disorder may be exacerbated by work stress but requires disorder-specific treatment; (2) failing to assess substance use disorders, which co-occur in approximately 20–30% of workers presenting with stress-related complaints; (3) overlooking medical conditions such as hypothyroidism, anemia, or sleep apnea that produce fatigue and cognitive complaints mimicking burnout; and (4) under-recognizing workplace bullying and harassment as etiological factors, which warrant distinct clinical and occupational responses.

Workplace mental health interventions are conventionally categorized into three tiers: primary (universal prevention), secondary (early intervention/indicated prevention), and tertiary (treatment and rehabilitation). A robust evidence base now exists for each tier, with important distinctions in effect sizes, cost-effectiveness, and sustainability.

Primary (Universal) Prevention: Organizational and Job Design Interventions

Primary interventions target the work environment itself — modifying job demands, increasing job control, improving social support, reducing role ambiguity, and enhancing procedural and distributive justice. A landmark Cochrane systematic review by Ruotsalainen et al. (2015) of organizational-level interventions for healthcare workers found that interventions combining cognitive-behavioral approaches with organizational change produced the largest effect sizes for reducing burnout (SMD = −0.38 to −0.55), while purely organizational interventions showed smaller but significant effects (SMD = −0.20 to −0.30). The critical finding was that individual-level interventions alone (e.g., resilience training, mindfulness) without accompanying organizational change had effects that attenuated within 6–12 months.

The IGLOO framework (Individual, Group, Leader, Organization, Overarching context), developed by Nielsen and colleagues, provides an implementation science model for multi-level intervention design. Evidence from the Danish PUMA study (Project on Burnout, Motivation, and Job Satisfaction) demonstrated that participatory organizational interventions — where workers actively co-design workplace improvements — reduced burnout and sickness absence, but only in organizational units where management actively supported the process, highlighting PSC as a moderating condition.

Secondary Prevention: Screening and Early Intervention

Secondary interventions include workplace mental health screening, stress management training, Employee Assistance Programs (EAPs), and targeted psychological interventions for at-risk workers. Meta-analytic evidence (Tan et al., 2014) for workplace-delivered CBT-based stress management programs shows effect sizes of d = 0.34–0.68 for reducing symptoms of stress, anxiety, and depression, with larger effects for indicated prevention (targeting symptomatic workers) than universal delivery.

Employee Assistance Programs (EAPs) are widely available — offered by approximately 80% of large employers in the United States — yet utilization rates remain low at 3–8% of eligible employees. Meta-analytic reviews (Richmond et al., 2017) suggest modest but statistically significant benefits for psychological distress and work functioning, with d = 0.24–0.30. The limited utilization is attributed to stigma, confidentiality concerns, and perceived lack of relevance — underscoring the role of PSC in enabling uptake.

Comparative Effectiveness: Individual vs. Organizational Approaches

A definitive meta-meta-analysis by Joyce et al. (2016) in The Lancet Psychiatry, synthesizing evidence from 22 meta-analyses and systematic reviews, compared the effectiveness of different workplace intervention types. Key findings included:

• CBT-based interventions showed the strongest evidence for reducing symptoms of depression and anxiety (SMD = −0.30 to −0.44)
• Organizational-level interventions showed moderate evidence, with effects more pronounced on job satisfaction and sickness absence than on symptom measures
• Physical activity interventions showed moderate evidence for depression prevention (SMD ≈ −0.30)
• Resilience training and mindfulness programs showed small effects (SMD = −0.12 to −0.25) with high heterogeneity and limited long-term follow-up

The critical clinical takeaway is that the most effective approach combines organizational-level hazard reduction with individual-level psychological support. Neither alone is sufficient, and the individual-only approach — which is far more commonly implemented — risks pathologizing structural workplace problems.

Return to work (RTW) after mental health-related sickness absence is a major clinical and occupational challenge. The median duration of absence for mental health conditions is approximately 60–80 working days in most OECD countries, and the recurrence rate of absence episodes is high — estimated at 30–40% within two years of initial return. Prolonged absence itself becomes a risk factor for chronicity: evidence demonstrates that the probability of ever returning to work declines sharply after 6 months of continuous absence, falling below 50% after 12 months.

Evidence-Based RTW Models

The most extensively studied RTW framework for mental health conditions is the Collaborative Care Model, adapted from the IMPACT study paradigm (Improving Mood — Promoting Access to Collaborative Treatment). Work-focused collaborative care integrates: (1) a care manager coordinating between the worker, treating clinician, employer, and occupational health service; (2) evidence-based treatment (typically CBT and/or pharmacotherapy); (3) a structured work-accommodation and graded activity plan; and (4) systematic outcome monitoring.

The Dutch AMMA study (Activating Management of Mental Health Absence) and similar trials demonstrated that adding a work-focused component to standard CBT significantly reduced time to full RTW compared to standard CBT alone. The landmark Blonk et al. (2006) RCT in the Netherlands randomized workers on sick leave due to adjustment disorders to: (1) CBT, (2) combined CBT + workplace intervention, or (3) care-as-usual. The combined intervention group achieved full RTW at a median of 60 days compared to 84 days for CBT alone and 120 days for care-as-usual. At 12-month follow-up, 89% of the combined group had sustained full RTW.

A Cochrane review by Nieuwenhuijsen et al. (2014) of interventions for reducing sickness absence in workers with depressive disorders found moderate-quality evidence that the addition of a work-directed intervention to clinical treatment reduced sickness absence duration by approximately 20–25 days (SMD = −0.40) compared to clinical treatment alone. They found insufficient evidence to recommend any single work-directed intervention type over another.

Individual Placement and Support (IPS)

For workers with severe mental illness (SMI) — including schizophrenia spectrum disorders and bipolar I disorder — the Individual Placement and Support (IPS) model is the gold standard. IPS integrates employment support directly into mental health treatment, emphasizing rapid job placement, worker choice, and ongoing job coaching. A meta-analysis of 14 RCTs (Modini et al., 2016) demonstrated that IPS participants were more than twice as likely to obtain competitive employment compared to traditional vocational rehabilitation (RR = 2.40, 95% CI: 1.99–2.90; NNT = 4). The competitive employment rate for IPS participants averaged 55% compared to 24% for controls.

Prognostic Factors for RTW Outcomes

Research consistently identifies the following prognostic factors:

• Positive RTW predictors: higher pre-absence job satisfaction, strong workplace social support, supervisor willingness to accommodate, early and sustained contact between worker and workplace during absence, graded RTW (partial hours increasing over time), internal locus of control, and mild-to-moderate symptom severity
• Negative RTW predictors: comorbid anxiety (especially avoidance behavior), substance use disorders, ongoing workplace conflict or bullying, low PSC in the return-to-work organization, older age (>50), longer absence duration, prior episodes of mental health-related absence, somatization, pending litigation or compensation disputes, and low self-efficacy for return

Notably, return-to-work self-efficacy — a worker's confidence in their capacity to resume work tasks — has emerged as one of the strongest individual-level predictors, with odds ratios of OR = 2.0–3.5 across multiple studies, and is a modifiable target for clinical intervention.

Comorbidity is the rule rather than the exception in work-related mental health presentations. Data from the WHO World Mental Health Survey indicates that approximately 45% of individuals meeting criteria for one mental disorder also meet criteria for at least one additional disorder. In the workplace context, specific comorbidity patterns have distinct implications:

• MDD + GAD: Co-occurrence estimated at 40–60%. This combination produces greater functional impairment, longer sickness absence, and lower RTW rates than either condition alone. Neurocognitive impairment (reduced working memory, attention, and processing speed) is more pronounced with comorbid anxiety-depression, directly impacting work capacity.
• MDD + Alcohol Use Disorder: Co-occurrence approximately 20–30%. Alcohol use disorder is frequently undetected in RTW assessments and significantly impairs treatment response — meta-analytic data show that comorbid AUD reduces antidepressant response rates from approximately 50–60% to 30–40%.
• Anxiety Disorders + Chronic Pain: Co-occurrence 30–50%, especially in workers with prior musculoskeletal injury. This combination creates a particular RTW challenge through fear-avoidance behavior, catastrophizing, and analgesic misuse. Neurobiologically, chronic pain and depression share overlapping circuitry in the anterior cingulate cortex, insula, and descending pain modulatory pathways (involving serotonin and norepinephrine), explaining their frequent co-occurrence and the efficacy of dual-action antidepressants (SNRIs) in both conditions.
• PTSD + Substance Use: Highly prevalent in first responders, military personnel, and healthcare workers exposed to traumatic events. Approximately 40–50% of individuals with PTSD have comorbid substance use disorder. This combination is associated with the poorest occupational outcomes and highest rates of disability separation.

From an organizational intervention perspective, comorbidity patterns reinforce the need for comprehensive clinical assessment rather than single-disorder, symptom-count-based approaches. Workplace screening tools that assess only depression (e.g., PHQ-9) without anxiety (GAD-7), alcohol use (AUDIT-C), and functional impairment measures will miss the complexity that drives prolonged disability.

When workers develop diagnosable mental health conditions, treatment effectiveness in the context of ongoing occupational demands has specific considerations beyond standard treatment guidelines.

Pharmacotherapy

SSRIs and SNRIs remain first-line pharmacotherapy for work-related depression and anxiety disorders. The STAR*D trial (Sequenced Treatment Alternatives to Relieve Depression) established that first-line SSRI (citalopram) achieves remission in approximately 28% of patients at Step 1, with cumulative remission rates of approximately 67% across four treatment steps. In the occupational context, medication selection should account for side effect profiles that impact work function: sedation (impairs safety-sensitive tasks), cognitive blunting (impairs creative and analytical work), and sexual dysfunction (affects quality of life and treatment adherence). Vortioxetine has emerged as a potentially preferred option for workers given its demonstrated benefits on cognitive function (processing speed, executive function, and verbal learning) — a feature not shared by most SSRIs, supported by the CONNECT and FOCUS trials showing NNT ≈ 6–7 for clinically significant cognitive improvement.

Regarding occupational outcome, a meta-analysis by Nieuwenhuijsen et al. (2008) found that antidepressant treatment alone did not significantly reduce sickness absence duration compared to placebo. This striking finding highlights that symptom reduction does not automatically translate to functional recovery — an additional work-directed intervention component is needed.

Psychotherapy

CBT, including its work-focused adaptations (W-CBT), has the strongest evidence base. Work-focused CBT adds components including: (1) identification and modification of work-related dysfunctional cognitions (e.g., "I cannot cope," "My colleagues will judge me"), (2) graded activity scheduling targeting work tasks, (3) communication skills for workplace re-entry conversations, and (4) relapse prevention planning anchored in workplace triggers. An RCT by Lagerveld et al. (2012) demonstrated that W-CBT produced RTW 65 days earlier than standard CBT, with equivalent symptom outcomes — indicating that the work-focused components specifically accelerate functional recovery.

Acceptance and Commitment Therapy (ACT) has emerging evidence in the workplace, with a meta-analysis (Flaxman et al., 2013) showing moderate effects on psychological flexibility, stress, and mental health (d = 0.37), though occupational outcome data remain limited. Problem-Solving Therapy (PST) is the recommended first-line brief intervention for adjustment disorders in several European occupational health guidelines, given its pragmatic focus and time-limited format (typically 4–6 sessions).

The regulatory landscape for workplace psychosocial risk management is rapidly evolving. The ISO 45003:2021 standard — the first international standard providing guidance on managing psychosocial risks in the workplace — provides an evidence-informed framework for identifying, assessing, and controlling psychosocial hazards within an occupational health and safety management system. While not legally binding, ISO 45003 is increasingly influencing national regulation and corporate governance standards.

In the European Union, the Framework Directive 89/391/EEC requires employers to assess and manage all workplace health risks, including psychosocial risks, though implementation varies dramatically across member states. Denmark, Sweden, and the Netherlands have the most developed regulatory and enforcement frameworks. Australia's model Code of Practice for Managing Psychosocial Hazards at Work (2022), published by Safe Work Australia, represents arguably the most specific national regulatory guidance globally, identifying 14 specific psychosocial hazards (including high job demands, low job control, poor support, bullying, remote work isolation, traumatic events, and poor organizational change management) and requiring employers to apply the hierarchy of controls — eliminate, substitute, isolate, engineer, administer — to psychosocial risks with the same rigor applied to physical hazards.

These regulatory developments are clinically significant because they shift the paradigm from reactive, individual-focused responses (treating the worker after illness develops) to proactive, organizational-level prevention — the approach supported by the strongest evidence. Clinicians involved in workplace mental health should be familiar with applicable psychosocial risk regulations in their jurisdiction, as these provide leverage for recommending organizational changes that individual clinical interventions cannot achieve alone.

Despite substantial progress, the workplace mental health evidence base has important limitations and active research frontiers:

Methodological Limitations

Publication bias and outcome reporting are significant concerns. A systematic assessment by Memish et al. (2017) found that most workplace mental health intervention studies are at moderate-to-high risk of bias, with particular concerns about blinding (often impossible for organizational interventions), selective outcome reporting, and short follow-up periods. Most studies measure outcomes at 3–6 months; sustained effects beyond 12 months are rarely assessed. The comparison condition in most RCTs is treatment-as-usual or waitlist control, rather than active comparators — limiting conclusions about comparative effectiveness.

The Context-Mechanism-Outcome Challenge

Organizational interventions are inherently complex, context-dependent, and difficult to standardize. The effectiveness of a participatory organizational change program depends on implementation fidelity, management commitment (i.e., PSC), worker engagement, concurrent organizational changes, and economic conditions — factors that are poorly controlled in most study designs. Realist evaluation methods and process evaluation are increasingly used to address this, but the field lacks the kind of large-scale definitive trials that exist for individual treatments.

Emerging Research Areas

• Digital and AI-Based Interventions: Smartphone-delivered CBT, chatbot-based counseling, and wearable-based stress monitoring are being evaluated. Early data show effect sizes comparable to in-person interventions for mild-to-moderate symptoms (d = 0.25–0.50), but adherence rates for digital interventions remain low (typically 30–50% completion) and effectiveness for occupational outcomes is unknown.
• Biomarker-Guided Prevention: Research is exploring whether inflammatory biomarkers (CRP, IL-6), cortisol profiles, or HRV (heart rate variability) measures could identify workers at imminent risk of clinical deterioration, enabling targeted early intervention. This remains experimental.
• Psychosocial Safety Climate Interventions: Despite strong evidence that PSC predicts mental health outcomes, very few controlled studies have evaluated interventions designed to improve PSC itself. This is a critical gap — the most powerful upstream predictor of workplace mental health has almost no intervention trial evidence. The PSC-Intervention framework developed by Dollard and colleagues is currently being evaluated in several organizational trials in Australia and Europe.
• The Changing Nature of Work: Remote work, gig economy employment, platform work, and AI-driven workplace changes create novel psychosocial hazards (isolation, boundary erosion, algorithmic management, job insecurity) that are not fully captured by existing models. The post-COVID research landscape is actively grappling with how hybrid and remote work modalities modify the demand-control-support dynamics that underpin traditional workplace mental health frameworks.

For clinicians treating workers with mental health conditions, the evidence reviewed above supports several practice principles:

• Assess the work environment, not just the worker. A clinical formulation that does not include an evaluation of psychosocial hazards (demands, control, support, justice, role clarity, bullying) is incomplete. The PSC framework can guide organizational-level assessment.
• Maintain work connection during absence. Early, supportive contact between the absent worker and their workplace — mediated by occupational health if necessary — is associated with shorter absence duration and better RTW outcomes.
• Advocate for graded RTW. Evidence consistently supports graduated return (increasing hours and responsibilities over weeks) rather than all-or-nothing approaches. Reasonable workplace accommodations — modified duties, flexible scheduling, reduced client-facing time — should be specified in treatment plans.
• Use work-focused treatment adaptations. Standard CBT should incorporate work-specific cognitive and behavioral targets. Treat the presenting disorder fully, but add occupational function as an explicit treatment outcome alongside symptom measures.
• Screen for comorbidity systematically. Anxiety, substance use, chronic pain, and insomnia co-occur frequently and independently predict poor occupational outcomes. Multi-domain screening (PHQ-9, GAD-7, AUDIT-C, ISI) should be routine.
• Recognize the limits of individual treatment. When workplace structural factors (e.g., chronic understaffing, bullying, organizational injustice) are primary drivers of distress, individual treatment alone is ethically insufficient and clinically inadequate. Clinicians have a role in documenting organizational hazards and recommending systemic change through occupational health and safety channels.

The ultimate goal is the integration of organizational prevention, early detection, evidence-based treatment, and structured RTW support into a seamless continuum of care — moving beyond the current fragmented landscape where occupational health, primary care, specialist mental health, and employer systems operate in silos.